skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > azole > diazole > pyrazoles > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > monocyclic heteroarene > azole > diazole > pyrazoles > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
organooxygen compound > oxacycle > oxazinane > morpholines > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > oxazinane > morpholines > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
organooxygen compound > carbonyl compound > ketone > methyl ketone > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic oxo compound > carbonyl compound > ketone > methyl ketone > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic oxo compound > carbonyl compound > ketone > methyl ketone > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
organooxygen compound > carbonyl compound > ketone > aromatic ketone > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic oxo compound > carbonyl compound > ketone > aromatic ketone > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic oxo compound > carbonyl compound > ketone > aromatic ketone > 1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one

Preferred term

1-(3'-/{1-[2-(morpholin-4-yl)ethyl]pyrazol-3-yl/}[1,1'-biphenyl]-3-yl)ethan-1-one  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C23H25N3O2

has_role

inchi

  • InChI=1S/C23H25N3O2/c1-18(27)19-4-2-5-20(16-19)21-6-3-7-22(17-21)23-8-9-26(24-23)11-10-25-12-14-28-15-13-25/h2-9,16-17H,10-15H2,1H3

inchikey

  • SLRQICGVSRRRDI-UHFFFAOYSA-N

mass

  • 375.464

monoisotopicmass

  • 375.19468

smiles

  • C=1C(=CC(=CC1)C=2C=CC=C(C2)C(=O)C)C3=NN(C=C3)CCN4CCOCC4

subset

  • 3_STAR

synonym EXACT

  • 1-(3'-{1-[2-(morpholin-4-yl)ethyl]-1H-pyrazol-3-yl}[1,1'-biphenyl]-3-yl)ethan-1-one

synonym RELATED

  • 1-(3'-(1-(2-morpholinoethyl)-1H-pyrazol-3-yl)biphenyl-3-yl)ethanone
  • liver receptor homologue 1 antagonist
  • LRH-1 antagonist
  • NR5A2 antagonist
  • nuclear receptor subfamily 5 group A member 2 antagonist

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:134272

Download this concept:

RDF/XML TURTLE JSON-LD